FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer.
Biochem Pharmacol
; 190: 114536, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33794187
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Cisplatin
/
Drug Resistance, Neoplasm
/
Receptor, Fibroblast Growth Factor, Type 3
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Biochem Pharmacol
Year:
2021
Document type:
Article
Country of publication: